KNE.V - Kane Biotech Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue283.278162.83536.174
Cost of Revenue92.63332.41716.895
Gross Profit190.645130.41819.279
Operating Expenses
Research Development427.593290.737653.916
Selling General and Administrative1,578.4381,000.415680.263
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-1,815.385-1,160.734-1,314.9
Income from Continuing Operations
Total Other Income/Expenses Net4.6916.3018.231
Earnings Before Interest and Taxes-1,810.694-1,154.434-1,306.668
Interest Expense89.86876.57787.597
Income Before Tax-1,900.562-1,231.011-1,394.265
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-1,900.562-1,231.011-1,394.265
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,900.562-1,231.011-1,394.265
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,900.562-1,231.011-1,394.265